ENDOBETES, INC.

Medtech · Private

Endoscopic anchoring system that stabilizes bypass devices in the gastrointestinal tract to treat obesity and type-2 diabetes

Grants
$251K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
5
2 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Stability and efficacy of an innovative endoscopic gastric bypass sleeve$250,585
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1773MEDICAL CARE CORPORATION——
1774ACTIVE LIFE SCIENTIFIC, INC.—$2.7M
1775WILD DOG PHYSICS, LLC——
1776ENDOBETES, INC.——
1777IntraVascular Imaging, Inc.——
1778CardioMech AS—$58M
1779INTEGRATED, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 5

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.